Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mesh Bio has developed the DARA® Health Intelligence Platform and the clinically approved digital twin software HealthVector®, which are deployed with leading healthcare providers across Singapore, Indonesia, Malaysia, and the Philippines. Their solutions have been validated in peer-reviewed publications and received regulatory approval from Singapore’s HSA for diabetes risk prediction. The company’s platforms are used to automate preventive health screening workflows and provide actionable insights for chronic metabolic diseases such as diabetes and kidney disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mesh Bio.